| Literature DB >> 17446862 |
M Chiara Maiuri1, Gaëtane Le Toumelin, Alfredo Criollo, Jean-Christophe Rain, Fabien Gautier, Philippe Juin, Ezgi Tasdemir, Gérard Pierron, Kostoula Troulinaki, Nektarios Tavernarakis, John A Hickman, Olivier Geneste, Guido Kroemer.
Abstract
The anti-apoptotic proteins Bcl-2 and Bcl-X(L) bind and inhibit Beclin-1, an essential mediator of autophagy. Here, we demonstrate that this interaction involves a BH3 domain within Beclin-1 (residues 114-123). The physical interaction between Beclin-1 and Bcl-X(L) is lost when the BH3 domain of Beclin-1 or the BH3 receptor domain of Bcl-X(L) is mutated. Mutation of the BH3 domain of Beclin-1 or of the BH3 receptor domain of Bcl-X(L) abolishes the Bcl-X(L)-mediated inhibition of autophagy triggered by Beclin-1. The pharmacological BH3 mimetic ABT737 competitively inhibits the interaction between Beclin-1 and Bcl-2/Bcl-X(L), antagonizes autophagy inhibition by Bcl-2/Bcl-X(L) and hence stimulates autophagy. Knockout or knockdown of the BH3-only protein Bad reduces starvation-induced autophagy, whereas Bad overexpression induces autophagy in human cells. Gain-of-function mutation of the sole BH3-only protein from Caenorhabditis elegans, EGL-1, induces autophagy, while deletion of EGL-1 compromises starvation-induced autophagy. These results reveal a novel autophagy-stimulatory function of BH3-only proteins beyond their established role as apoptosis inducers. BH3-only proteins and pharmacological BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin-1 and Bcl-2 or Bcl-X(L).Entities:
Mesh:
Substances:
Year: 2007 PMID: 17446862 PMCID: PMC1868901 DOI: 10.1038/sj.emboj.7601689
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598